Compass Group PLC Sponsored ADR (CMPGY)
Compass Diversified Preferreds: One Of The Lowest Risk, Very High Yields Today
A rock-solid 7.4x coverage ratio and strong insider alignment make this dividend very low risk. Near 9% yield, upside to par, and qualified dividends for taxable accounts? Yes, please. This preferred stock could hand you high income and low risk—perfect for retirement portfolios.
Compass (COMP) Upgraded to Buy: Here's What You Should Know
Compass (COMP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Compass considering buying Berkshire Hathaway's real estate brokerage business: WSJ
CNBC's Becky Quick reports on the latest news.
Despite Fast-paced Momentum, Compass (COMP) Is Still a Bargain Stock
Compass (COMP) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Compass Diversified Preferred C Stock: Appealing +8% Yield In A Volatile Market
Preferred shares, like Compass Diversified's Series C, offer income protection and higher yields, making them a strong hedge against market volatility. Compass Diversified's diversified portfolio and robust Q4 2024 results, with 14% YoY sales growth and 25% adjusted EBITDA growth, support a positive outlook. CODI.PR.C trades at a 5% discount to par value, offering an 8.3% yield and cumulative dividends, providing income-focused investors with attractive returns.
Compass Pathways: Betting On The Future Of Psilocybin Therapy
Compass Pathways is positioned to leverage regulatory tailwinds and compelling clinical data, despite broader skepticism and high cash burn in the psychedelic biotech sector. The company has a financial cushion with cash reserves of $165.1 million, providing 4-6 quarters of runway before needing additional capital. COMP360 shows promise in treating treatment-resistant depression and PTSD, with significant clinical trial results and potential long-term economic benefits.
Why Compass Stock Was Moving Higher This Week
Shares of Compass (COMP -8.18%), the nation's largest real estate brokerage, were climbing this week after the company delivered better-than-expected results in its fourth-quarter earnings report and gained market share in a challenging real estate environment.
Are You Looking for a Top Momentum Pick? Why Compass, Inc. (COMP) is a Great Choice
Does Compass, Inc. (COMP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Compass: Hold Rated As I Am Still Very Worried About The Risks
I recommend a hold rating for Compass due to concerns about high mortgage rates and potential regulatory risks despite strong execution. COMP reported ~$1.4 billion in revenue, driven by 25.9% y/y growth and market share gains, with strong agent retention and transaction growth. The private inventory strategy shows promise, but regulatory scrutiny and high mortgage rates could impact COMP's growth trajectory.
Compass (COMP) Is Attractively Priced Despite Fast-paced Momentum
Compass (COMP) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Stellantis pauses retooling at Canada factory slated to build Jeep Compass
Stellantis is pausing work on its next-generation Jeep Compass compact SUV including retooling a plant in Canada designated to build the vehicle, the company said Thursday.
Compass: Still One Step Ahead Of The Competition
Shares of Compass soared ~10% after reporting Q4 results, showcasing acceleration in growth, 65bps of y/y market share expansion, and significant margin gains. Compass continues to outperform the real estate market, expanding into new regions and acquiring Christie's real estate division, boosting its market share and growth potential. The company's Q4 revenue surged 26% y/y to $1.38 billion, with organic growth contributing 21% y/y, far outpacing the broader industry (where transaction growth was just shy of 7% y/y).
